Biodesix, Inc. (BDSX)
$25.00-2.72%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $204M
- Beta
- 0.55
- P/E (TTM)
- -7.89
- Short % float
- 4.33%
- Days to cover
- 1.8
- SI change
- -5.7%
- 1W
- -10.59%
- 1M
- -8.76%
- vs SPY 1W
- -10.45%
- vs SPY 1M
- -11.27%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on BDSX?
- LOPJLB’s latest quantitative signal on Biodesix, Inc. (BDSX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BDSX in?
- Biodesix, Inc. (BDSX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Biodesix, Inc. (BDSX) do?
- Biodesix, Inc. is a data-driven diagnostic solutions provider operating across the United States. Its primary focus includes a comprehensive suite of blood-based lung tests, marketed as the Nodify Lung Nodule Risk Assessment (which includes Nodify XL2 and Nodify CDT). These assessments enable clinicians to evaluate the risk of lung cancer in patients with suspicious nodules, aiding in the recla…